Ya-feng Lv

Hubei Key Laboratory Of Tumor Microenvironment And Immunotherapy
Xiaoxita, 443002, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

The human induced pluripotent stem cell line CTGUi-002A was generated from a Perrault syndrome patient.

The human induced pluripotent stem cell line CTGUi-002A was generated from a Perrault syndrome patient.

Journal: Stem cell research
Published: November 23, 2025

Gene therapy for Krabbe disease: evidence from mouse and canine models.

Gene therapy for Krabbe disease: evidence from mouse and canine models.

Journal: Gene
Published: October 12, 2025

Patient-derived TWNK variants recapitulate multisystem Perrault syndrome pathology in a mouse model.

Patient-derived TWNK variants recapitulate multisystem Perrault syndrome pathology in a mouse model.

Journal: Mitochondrion
Published: September 20, 2025

AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse.

AAV2-mediated ABD-FGF21 gene delivery produces a sustained anti-hyperglycemic effect in type 2 diabetic mouse.

Journal: Life sciences
Published: November 03, 2024

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2.

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2.

Journal: BMC cancer
Published: September 06, 2023

Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.

Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.

Journal: Stem cell research
Published: April 25, 2023

Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.

Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.

Journal: Stem cell research
Published: January 03, 2023

Production and characterization of human induced pluripotent stem cell line (PUMCi002-A) from a Krabbe patient related control to study disease mechanisms associated with GALC mutation.

Production and characterization of human induced pluripotent stem cell line (PUMCi002-A) from a Krabbe patient related control to study disease mechanisms associated with GALC mutation.

Journal: Stem cell research
Published: September 26, 2022

Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease.

Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease.

Journal: Stem cell research
Published: June 22, 2020

Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice.

Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice.

Journal: Oncology research
Published: January 24, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026